Santen Pharmaceutical Co Ltdis A Multinational Pharmaceutical Company Based In Japanspecializing In Ophthalmologyfounded In 1890 In Osakasanten Initially Focused On Cold Medications Before Shifting Its Emphasis To Eye Care Productsthe Company Has Become A Global Leader In Eye Healthwith Over 90Of Its Sales Coming From Prescription Pharmaceuticals Santen S Product Offerings Include Mydriaticsanti Inflammatory Eye Dropsand Treatments For Glaucomadry Eyeand Retinal Diseasesthe Company Also Has A Range Of Over The Counter Productsincluding Its First Ophthalmology Productdaigaku Eye Dropsintroduced In 1899Santen Is Committed To Innovationfocusing On Drug Delivery Systemsregenerative Medicineand Digital Therapeutics For Various Eye Conditions The Company Serves Healthcare Professionals And Patients With Eye Disordersdistributing Its Products Globallyparticularly In Asiaeuropeand North Americasanten Emphasizes Accessibility And Has A Strong Corporate Strategy That Prioritizes Ophthalmology While Pursuing Partnerships For Advanced Therapies And Sustainable Healthcare Solutions
